Biohaven Pharmaceutical Aktie
WKN DE: A2DQ7W / ISIN: VGG111961055
03.03.2025 13:59:26
|
Biohaven Ltd. Q4 Loss Increases, Misses Estimates
(RTTNews) - Biohaven Ltd. (BHVN) released Loss for its fourth quarter that increased from last year and missed the Street estimates.
The company's bottom line totaled -$186.84 million, or -$1.85 per share. This compares with -$144.76 million, or -$1.81 per share, last year.
Excluding items, Biohaven Ltd. reported adjusted earnings of -$173.26 million or -$1.71 per share for the period.
Analysts on average had expected the company to earn -$1.47 per share. Analysts' estimates typically exclude special items.
Biohaven Ltd. earnings at a glance (GAAP) :
-Earnings: -$186.84 Mln. vs. -$144.76 Mln. last year. -EPS: -$1.85 vs. -$1.81 last year.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Biohaven Pharmaceutical Holding Co Ltd Registered Shsmehr Nachrichten
Keine Nachrichten verfügbar. |